215 results on '"Heizmann W"'
Search Results
2. Brucellosis: Serological Methods Compared
3. Multilaboratory Evaluation of an Agar Diffusion Disk Susceptibility Test for Rapidly Growing Anaerobic Bacteria
4. MRSA: Resistenzmechanismen, Epidemiologie, Risikofaktoren, Prophylaxe, Therapie
5. Kriterien zur Abgrenzung der Kombinationen Piperacillin/Tazobactam und Piperacillin/Sulbactam
6. Häufigkeit, Klinik und Letalität der Pneumocystis carinii Pneumonien bei nicht-HIV-induzierter Immundefizienz
7. Invasive Infektionen durch Streptokokken der Gruppe A mit schwerer Verlaufsform als „Toxic Shock-like Syndrome“– ein intensivmedizinisch zu behandelndes Krankheitsbild
8. In vitro activity of daptomycin-metronidazole combinations against mixed bacterial cultures: Reduced activity of metronidazole againstBacteroides species in the presence ofEnterococcus faecalis
9. Efficacy of sulbactam in an in vitro model of mixed aerobic/anaerobic infections
10. Antimicrobial chemotherapy-resistance
11. Perioperative antibiotics to improve outcome?
12. Evaluation of rambach agar for rapid detection ofSalmonella in human feces
13. Erratum: Antimicrobials: A global alliance for optimizing their rational use in intra-abdominal infections (AGORA). [World J Emerg Surg. 11, (2016) (33)] DOI: 10.1186/s13017-016-0089-y
14. Isolation ofEwingella americana from a patient with conjunctivitis
15. Comparative in vitro activity of cefpodoxime against anaerobes other than bacteroides fragilis
16. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA) (vol 11, 33, 2016)
17. Häufigkeit, Klinik und Letalität der Pneumocystis carinii Pneumonien bei nicht-HIV-induzierter Immundefizienz
18. Erratum to: Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA)
19. Pippinische Schenkung
20. Problems in the detection ofPneumocystis carinii by indirect immunofluorescence
21. Comparison of four commercial microdilution systems for susceptibility testing of anaerobic bacteria
22. Evaluation of the cobas bact automated system for susceptibility testing of enterobacteriaceae, pseudomonas aeruginosa, and enterococcus faecalis to azlocillin, mezlocillin, and ciprofloxacin compared to NCCLS and DIN standards
23. Benefit and advantage to clinicians of a computer-assisted microbiological diagnosis and database system
24. Die Rolle coagulasenegativer Staphylokokken in Mischinfektionen: Assoziationstestungen als in-vitro-Modell
25. In vitro activity of ampicillin plus sulbactam against anaerobes compared to ampicillin and cefoxitin
26. Ampicillin plus Sulbactam: In Vitro Activity against Anaerobes
27. Computer-aided densitometric analysis of protein patterns ofClostridium difficile
28. Association experiments with aerobic and anaerobic pathogens: a model of in-vitro susceptibility testing in mixed infections. Activity of enoxacin, clindamycin, and metronidazole
29. Comparison of the Cobas-Bact five-hour susceptibility testing system with the NCCLS agar diffusion and dilution methods
30. Nutzen und Vorteile eines computergesteuerten mikrobiologischen Diagnose- und Datenerfassungssystems für die Antibioticatherapie in der Chirurgie
31. Surveillance cultures and benefit of laminar airflow units in patients undergoing bone marrow transplantation
32. New developments in medical microbiology: computer-assisted diagnosis and automated instruments
33. Activity of Enoxacin, Clindamycin, and Metronidazole in Association Experiments with Aerobic and Anaerobic Pathogens
34. Prospective observational multi-centre trial of tigecycline in the treatment of severely ill patients with complicated infections
35. Three Cases of Cutaneous Diphtheria in Travelers to Africa
36. Empfindlichkeit klinisch wichtiger Bacteroides spp. gegenüber den Kombinationen Enoxacin-Metronidazol und Enoxacin-Clindamycin
37. Clinical efficacy of tigecycline used as monotherapy or in combination regimens for complicated infections with documented involvement of multiresistant bacteria
38. Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studies
39. Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies
40. Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies
41. Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies
42. Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studies
43. Sind Monotherapien mit β-Laktamantibiotika noch zeitgemäß?
44. Ciprofloxacin Therapy for Postoperative Urinary Tract Infections
45. Katzenkratzkrankheit: Bartonella-henselae-Antikörper und Nukleinsäurenachweis bei regionaler Lymphadenopathie
46. Rocky-Mountain-Fleckfieber
47. Puerperalsepsis durch Streptokokken der Gruppe A mit schwerer Verlaufsform als »Toxic Shock-like Syndrome«
48. HRÚTUR HERJÓLFSSON: A VIKING TOO LARGE FOR HIS WIFE? URO-PHILOLOGICAL WORKUP OF A 1000 YEAR OLD STORY
49. Aus der Frühzeit der Goldbrakteatenforschung
50. Criteria for comparison of the combinations piperacillin/tazobactam and piperacillin/sulbactam
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.